Skip to main content

October 2015

 

 

academics

 

Clinical research courses

US Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10 to 4 to recommend the approval of lesinurad 200mg tablets for the treatment of hyperuricemia associated with gout, in combination with a xanthine oxidase inhibitor (XOI). All 10 who backed the drug, lesinurad, qualified their vote by urging the FDA to ask AstraZeneca for studies after the drug's launch to gauge its long-term effectiveness and safety.

A new study has suggested that the chemical produced by decaying tissue of dead bodies can produce a fight-or-flight response in humans. This is the first study to show that a scent emanating from a specific chemical compound called putrescine can be processed as a threat signal. The study was published in Frontiers in Psychology.

There is good news for people suffering from hair loss. In experiments with mouse and human hair follicles, researchers have found that certain existing drugs promote rapid and robust hair growth when directly applied to the skin.

Never before in the history of polio have so few children contracted the virus, but the international community cannot rest until the number of cases is zero, the UN Children's Fund (UNICEF) said on the eve of World Polio Day.